Signals · mentaratherapeutics.com

What just happened at Mentara Therapeutics

Last updated

Mentara Therapeutics raised initial funding to advance its asset portfolio and launch a Phase 2 clinical study. Backed by SPRIM Global Investments and former shareholders of EuMentis Therapeutics on 2026-10-12. It was reported by finsmes.com.

The evidence, dated and sourced

  1. — Funding: Mentara Therapeutics raised initial funding to advance its asset portfolio and launch a Phase 2 clinical study. Backed by SPRIM Global Investments and former shareholders of EuMentis Therapeutics.
    Press / news →

How this is sourced

Every row above links to the document it came from — an SEC filing on EDGAR, or the announcement a publisher ran. Fundz does not paraphrase a source it has not stored, and each row is labelled sec_filing or press_or_news so you can see which you are reading. Funding rounds come from SEC Form D filings and announcements; 8-K events come from the filings themselves. No contact or people data appears here.

Companies with recent events

Get this via API or MCP

The same evidence, as JSON, for your own agents. Quickstart → · MCP endpoint https://api.fundz.net/v1/agent/mcp

curl -s -X POST https://api.fundz.net/v1/agent/why_now \
  -H "X-Fundz-Key: $FUNDZ_KEY" -H "Content-Type: application/json" \
  -d '{"domain": "mentaratherapeutics.com"}'